Misoprostol Versus Oxytocin for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term
NCT ID: NCT06343480
Last Updated: 2024-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2020-09-01
2021-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol
NCT05215873
A Study Comparing Vaginal Misoprostol and Intravenous Oxytocin for Induction of Labor
NCT01634854
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
NCT06968481
Amniotomy and Oxytocin for Augmentation of Labour
NCT02318121
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
NCT04478942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study compared the efficacy of misoprostol and oxytocin for induction of labour in parturients with term PROM. This was a double blind randomized controlled trial on the efficacy of sublingual misoprostol versus oxytocin titration in women with term PROM at the Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA) and Mile 4 Hospital Abakaliki. 240 Participants were divided into two groups of 120 participants each. Group A received 25 mcg of sublingual misoprostol and titration of 500 ml of Ringer's lactate solution as placebo with 5ml of sterile water injected into it while group B underwent immediate induction of labour with titration of 5 units of oxytocin in a 500 ml of Ringer's lactate solution and received one tablet of 100mg Vitamin C as placebo. The primary outcome measure was the mean induction delivery interval. The secondary outcome measures were Caesarean section rate, the incidence of uterine hyper-stimulation, tachysystole or hypertonus, APGAR scores at the first and fifth minute and NICU admission. Data analysis was done using statistical Package for Social Science (IBM SPSS) software (version 20, Chicago IL, USA). Continuous variables were presented as mean and standard deviation (Mean ± SD), while categorical variables were presented as numbers and percentages. Categorical variables were analyzed using Chi-square while means were compared using T-test. A difference with a P value of \<0.05 was considered significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
first arm - Oxytocin titration
Received vitamin c 100mg as placebo and had Oxytocin titration in 500ml of ringers lactate for labour induction
Labour Induction
the use of misoprostol sublingual for labour induction compared with oxytocin titration in parturients with prelabour membrane rupture at term.
second arm - Misoprostol give sublingual
received 25mcg of Misoprostol and titration of plane 500ml of ringers lactate as placebo
Labour Induction
the use of misoprostol sublingual for labour induction compared with oxytocin titration in parturients with prelabour membrane rupture at term.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Labour Induction
the use of misoprostol sublingual for labour induction compared with oxytocin titration in parturients with prelabour membrane rupture at term.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancy at term
* prelabour rupture of membranes
* not having contraction
* Bishop scoe 5 or less
Exclusion Criteria
* declined consent
* contraindication for vaginal delivery
* multiple gestation
* medical conditions co-existing with pregnancy
* grand multiparous parturients
* previous caesarean section scar
* already having contractions
* has intrauterine foetal death
* bishop sore \>5
15 Years
44 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Teaching Hospital Abakaliki
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nwali Matthew Igwe
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria
Federal Teaching Hospital, Abakaliki
Abakaliki, Ebonyi State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMVOT2024CT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.